Blueberries Medical Corp.
BBM
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 51.18% | 47.58% | 41.29% | 59.59% | -7.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.18% | 47.58% | 41.29% | 59.59% | -7.69% |
| Cost of Revenue | 90.98% | 36.01% | 44.10% | 46.63% | -25.33% |
| Gross Profit | 11.31% | 68.39% | 36.99% | 91.19% | 20.66% |
| SG&A Expenses | 17.40% | 19.44% | 11.81% | -26.85% | -6.01% |
| Depreciation & Amortization | -12.64% | -45.98% | -38.00% | -30.94% | 5.46% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.03% | 13.53% | 10.45% | -18.20% | -7.48% |
| Operating Income | -15.12% | -5.63% | -3.43% | 34.52% | 7.41% |
| Income Before Tax | -31.25% | -14.90% | -10.05% | 31.01% | 9.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.25% | -14.90% | -10.05% | 31.01% | 9.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.25% | -14.90% | -10.05% | 31.01% | 9.77% |
| EBIT | -15.12% | -5.63% | -3.43% | 34.52% | 7.41% |
| EBITDA | -17.98% | -14.53% | -9.09% | 35.06% | 1.17% |
| EPS Basic | 3.70% | 25.71% | 36.96% | 62.50% | 37.21% |
| Normalized Basic EPS | -7.69% | 22.22% | 36.00% | 64.52% | 48.00% |
| EPS Diluted | 3.70% | 25.71% | 36.96% | 62.50% | 37.21% |
| Normalized Diluted EPS | -7.69% | 22.22% | 36.00% | 64.52% | 48.00% |
| Average Basic Shares Outstanding | 26.44% | 37.13% | 51.48% | 81.95% | 69.16% |
| Average Diluted Shares Outstanding | 26.44% | 37.13% | 51.48% | 81.95% | 69.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |